muromonab-cd3 and Kidney-Diseases

muromonab-cd3 has been researched along with Kidney-Diseases* in 1 studies

Other Studies

1 other study(ies) available for muromonab-cd3 and Kidney-Diseases

Article	Year
IP BMC nephrology, 2018, 06-15, Volume: 19, Issue:1 The expression of IP. Increased expression of IP. This study identified a novel pathway in which the IP Topics: Adenosylhomocysteinase; Animals; Antibiotics, Antineoplastic; Apoptosis; Calcium; Calcium Channels; Cells, Cultured; Doxorubicin; Endoplasmic Reticulum; HSP70 Heat-Shock Proteins; Kidney Diseases; Macrocyclic Compounds; Male; Membrane Proteins; Mice; Mitochondria; Oxazoles; Podocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Voltage-Dependent Anion Channel 1	2018

Article

Year

BMC nephrology, 2018, 06-15, Volume: 19, Issue:1

The expression of IP. Increased expression of IP. This study identified a novel pathway in which the IP

Topics: Adenosylhomocysteinase; Animals; Antibiotics, Antineoplastic; Apoptosis; Calcium; Calcium Channels; Cells, Cultured; Doxorubicin; Endoplasmic Reticulum; HSP70 Heat-Shock Proteins; Kidney Diseases; Macrocyclic Compounds; Male; Membrane Proteins; Mice; Mitochondria; Oxazoles; Podocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Voltage-Dependent Anion Channel 1

2018